Liraglutide in combination with acitretin for severe recalcitrant psoriasis

Authors


  • Funding sources: none.
  • Conflicts of interest: B.K. is in receipt of unrestricted research grants from Abbott Ltd, Pfizer and Janssen, and works as an advisor to and consultant for Abbott Ltd, Pfizer and Janssen.

No abstract is available for this article.

Ancillary